When AI Starts Acting: Why Healthcare Needs an Orchestration Layer, Not Just Principles

“Agentic AI promises transformative enterprise productivity, but scalability is severely bottlenecked by agent sprawl, fragmented data, complex integrations, and security risks. Product leaders must implement orchestration layers with behavioral guardrails to deploy agentic AI safely at enterprise scale.”

The use of general-purpose artificial intelligence models lacking specialized training, contextual awareness, and industry-tailored guardrails, further scalability challenges by introducing distinct operational and security risks. A domain-specific AI orchestration layer can ensure that healthcare organizations proactively overcome the critical challenges of uncoordinated workflows, disconnected data access, and prohibitive agent sprawl.

How should healthcare organizations evaluate AI orchestration vendors for governance, auditability, and regulatory compliance?

Look for solutions with symbolic guardrails that are domain-specific guarantee that unsafe or invalid actions cannot be executed— a critical AI orchestration layer in healthcare.

Gartner® research in Emerging Tech: AI Vendor Race — Top Challenges for Scaling Agentic AI

“By 2028, global enterprises will scale to over 150,000 agents, creating massive agent sprawl and critical IT management challenges, up from 15 in 2025.”

Understanding The Enterprise Challenge in Healthcare

The first obstacle is structural. Without a centralized orchestration layer, healthcare organizations struggle to manage the growing population of non-human identities (NHIs) that agents create. Each system runs its own disconnected agents, which raises governance and compliance risk and deepens vendor lock-in. Unmonitored agents can also behave like insider threats, leaking data, taking unauthorized actions, or mishandling sensitive information in ways that invite severe regulatory penalties. Because agentic AI could create thousands of new NHIs with system access, the enterprise attack surface expands considerably.

Technical limitations compound the problem. Agents working across fragmented data environments suffer from high latency, which makes real-time autonomous decisions unrealistic. Large language models are probabilistic and lack transparent reasoning, so they can produce errors that go undetected and are hard to trace or audit. If catching those errors demands constant human supervision, enterprises will simply reject the solution.

Healthcare needs an AI orchestration layer built for them, not just principles.

“Without a centralized enterprise orchestration layer, organizations are building narrow, task-specific agents in isolated silos using disparate platforms, which results in fragmented execution and suboptimal performance.”

Why Healthcare Governance Must Evolve Beyond Intelligence

Healthcare’s current approach to AI governance was built for systems that generate insights or recommendations. It was not designed for AI that can interpret policy, coordinate work across systems, and initiate action. Once AI becomes part of execution, governance must change with it.

As AI agents begin to interpret policies, coordinate workflows, and initiate actions across healthcare systems, organizations need clear boundaries around what AI is authorized to do, what evidence supports its decisions, and when human intervention is required.

The central question is not whether a human stays “in the loop.” It is whether the organization has defined four things: the AI’s authority, the conditions under which it can act, the evidence required to support each action, and the point at which responsibility returns to a person.

“The absence of comprehensive observability tools also prevents organizations from tracking complex decision lineage, resulting in “silent failures,” multiturn conversational degradation, and a lack of explainability that erodes trust in automated outcomes.”

Moving From Principles to Enforceable Controls

Meeting that standard takes more than principles and review committees. Clinical and operational policies must become enforceable controls, and that is the job of the AI orchestration layer.

Most enterprises think about AI in terms of models and agents, but the harder problem is what surrounds them. An orchestration layer sits between agents and the systems they touch, and it enforces governance at the moment of action. Before an agent acts, the layer checks whether it is authorized to do so and applies the relevant policy. If a request falls outside defined limits, it routes the exception to a person for review. It records every action alongside the evidence that supported it, so each decision can be traced to the policy, evidence, and reasoning behind it. And when a workflow requires human judgment, it pauses execution until that judgment is given.

That is what Zyter’s AI orchestration layer, Symphony, does. Symphony coordinates agent, system, and human actions across every workflow, enforcing governance, maintaining full decision lineage, and building in continuous learning at every step. It is not an agent or a chatbot. It is the control plane that makes every workflow run correctly, consistently, and smarter over time.

Because the controls live in the layer rather than in each agent, autonomy can be calibrated to risk and demonstrated performance, and it can be restricted or withdrawn when performance changes, without rebuilding the agents themselves.

“Investing in real-time observability, traceability, and policy-as-code frameworks and tools is essential for detecting and stopping rogue or malicious AI agent actions.”

Rethinking Human Oversight

The healthcare industry should also be rigorous about what human oversight means. Requiring a person to approve every decision may not reduce risk or error if the volume and design of the work make meaningful review impossible. In those cases, human involvement becomes a procedural safeguard rather than an effective one. Effective oversight depends on whether reviewers have the information, time, and authority to challenge or intervene in an AI decision.

In healthcare, input from expert medical minds adds critical value over automated systems or AI when data is sparse, or situations fall outside the norms. In outlier scenarios, machine learning models may degrade because they rely on historical patterns and governance. The change in context makes human cognition and clinician oversight increasingly valuable in outlier scenarios.

A Practical Path Forward for Product Owners

Responsible AI governance must be reflected in how work is performed, how decisions are made, and who remains accountable for the outcome. For healthcare organizations, that offers a practical basis for expanding AI use without compromising clinical judgment or accountability.

The organizations that succeed with agentic AI will be those that treat governance as part of the work itself, with clear authority, traceable decisions, calibrated autonomy, and oversight that is built to be meaningful.

Healthcare leaders should redesign workflows around desired outcomes rather than simply layering AI onto existing processes. In oncology and specialty care, for example, AI can handle information extraction, summarization and protocol management, allowing clinicians to focus on complex decisions and patient care. Reframing workflows to include trust-building mechanisms are also critical to AI orchestration and agentic AI adoption in healthcare. For example, providing clinicians with access to the evidence behind AI recommendations and systems that clearly signal uncertainty.

How healthcare organizations should evaluate AI orchestration vendors for governance, auditability, and regulatory compliance

Healthcare organizations should evaluate AI orchestration vendors on how they govern execution, not only on model performance. Key questions that product managers and technology leaders in healthcare should ask include how policies inform actions, where human review occurs, how exceptions escalate, and whether decisions can be traced to their context and responsible actors. Organizations should also assess whether AI agents have consistent access to trusted data and relevant business context across systems. Look for solutions that support human-in-the-loop operations, policy-aware orchestration, and end-to-end decision lineage. Buyers should also verify security controls and compliance evidence for the specific product and deployment being considered.

Emerging Tech: AI Vendor Race — Top Challenges for Scaling Agentic AI, By: Kiumarse Zamanian, Alfredo Ramirez IV, Aakanksha Bansal, Christine Tenneson, Ethan Cai, 10 July 2026

Gartner is a trademark of Gartner, Inc. and/or its affiliates.

Looking for expert guidance on how to navigate transformative enterprise productivity in 2027? Download Gartner® Emerging Tech: AI Vendor Race — Top Challenges for Scaling Agentic AI. Get insights into how to implement orchestration layers with behavioral guardrails and deploy agentic AI safely at enterprise scale.